EPB41L3 and lung carcinoma: Based on our findings, the expression of DAL-1 is downregulated in lung cancer compared to normal tissues and significantly associated with disease progression, we suggest that decreased expression of DAL-1 may occur in the early stages of tumor development as well as be essential in maintaining tumorigenesis.